Fully networked therapy platforms

Developing, integrating, collaborating. As a specialist for user-friendly drug delivery systems, Pulmotree Medical Partnering offers fully networked therapy platforms.

For this purpose, we holistically bring together inhalers and nebulisers, diagnostic tools and medications and configure them into individual therapeutic ecosystems. Using our own products. Using respiratory therapy products available on the market. In partnership with our clients.


Customised drug delivery systems

With many advantages – and interfaces. Our system is designed as an all-in-one networking platform so any hardware can be added via plug and play. Fully customisable. Individually configurable. Requires no costly new development effort. Patients then get major added value. Maximum connectivity also increases the attractiveness of partner products.

Partnering means connecting

A networked therapy platform enables patients with respiratory diseases to receive holistic treatment from a single source. Therapy-relevant data and information can be transferred to the relevant medical professionals or study institutes. For our pharmaceutical partners, the investment required for customised drug delivery systems can be reduced as can product development times.

In short, efficiency and patient benefits go up, time to market goes down.
How we work

Integrated. Connected. From a single source.

Pulmotree Medical Partnering responds to the needs of partners. Holistically. Connected. And from a single source. We therefore give clients precisely the expertise that the project requires. Our core expertise has become fully anchored within the company. Continuous access to specialists is available.

Short-term needs are provided via a competent partner network that can be integrated into a team for the duration of a project. Processes can then be streamlined by centralising activities as well as core documentation tasks to enable highly efficient working.

Clear communications between all parties involved is also a priority and takes place via single points of contact, participative and full integration into our activities, and the transparency of a single source.

The path to a networked therapy platform:
  • The basis is a fully developed clinical study device which can be adapted to the drug and patient group as required
  • Feasibility study (in our Aerosol Lab or that of our partner)
  • Initial clinical studies
  • Configuration of the developed platform to a serial device
  • Phase 3 study/bridging study
  • Approval support
  • Post market support
Pulmotree Medical Partnering benefits
  • Harmonised team of specialists
  • Shorter “time to market” due to modular therapy platform
  • Transparency via integrative project management
Dynamism from a network strategy

Breathing agility and efficiency

It’s the team, rather than any team: the Pulmotree network strategy enables us to support every project flexibly, agilely and thus highly efficiently.

This applies to both individual device development and holistic therapeutic ecosystems. Our network strategy enables us to get the right specialist on board for any area, from basic devices such as inhalers and nebulisers through to spirometers and apps for intelligently networking therapy modules. We can then act quickly and flexibly as well as meet customer needs as a full one-stop-shop.


Getting the right expertise at the right time creates lean structures and efficient processes. The strategy’s basis is Pulmotree Medical’s network of highly specialised companies. These are not short-term freelancers, but loyal partners with close ties and working under the highest confidentiality.
We selectively include them in projects to complement Pulmotree’s core competencies and together create a unique added value for customers.